Virtual Medicinal Product (VMP) - Dexamethasone (base) 6.6mg/2ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Dexamethasone (base) 6.6mg/2ml solution for injection ampoules Start Date 31-05-2018 End Date
Previous Name Previous Name Dexamethasone 6.6mg/2ml solution for injection ampoules Start Date 01-03-2013 End Date 30-05-2018
Abbreviated Name Abbreviated Name Dexamethasone (base) 6.6mg/2ml inj ampoules Start Date 31-05-2018

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
2
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous, Intramuscular, Intralesional, Intraarticular, Intrabursal, Subcutaneous, Infiltration, Subconjunctival
Form
Solution for injection
Ontology Form/Route
solutioninjection.intralesional, solutioninjection.intramuscular, solutioninjection.intraarticular, solutioninjection.intrabursal, solutioninfusion.intravenous, solutioninjection.intravenous, solutioninjection.subcutaneous, solutioninjection.infiltration, solutioninjection.subconjunctival
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
H02AB02
BNF Codes
  • BNF code 06030200
SNOMED Codes
Code Start Date End Date
22153811000001101 01-03-2013

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Dexamethasone sodium phosphate Based on Base Substance Dexamethasone 3.3 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 ampoule
10 ampoule